INTRODUCTION
House dust mites (HDMs) are a major source of allergens in patients with allergic disorders such as atopic dermatitis, asthma, and rhinitis (Gregory and Lloyd, 2011) , and administration of HDM extracts to mice causes allergic airway inflammation with similarities to that seen in asthma (Johnson et al., 2004) . HDMderived antigens can induce barrier disruption of lung epithelial cells, thereby facilitating allergen sensitization that is dependent on Toll-like receptor 4 (TLR4) (Hammad et al., 2009; Trompette et al., 2009 ). In particular, HDM-derived cysteine proteases such as Der p1 can disrupt the tight junctions between epithelial cells, which are thought to contribute to development of allergic disorders (Herbert et al., 1995; Nakamura et al., 2006; Wan et al., 1999) .
Similarly, the plant-derived cysteine protease, papain, which is homologous to HDM-derived Der p1 and human cathepsin B (Chua et al., 1988) , is known to induce airway inflammation in humans and is a cause of occupational asthma (Milne and Brand, 1975) . In mice, we and others showed that papain can induce production of an alarmin, interleukin-33 (IL-33), a member of the IL-1 family of cytokines, by lung epithelial cells, followed by induction of IL-5 and IL-13 production by lung natural helper (NH) cells, resulting in development of IL-4 and IL-13-STAT6-dependent eosinophilic airway inflammation even in the absence of acquired immune cells such as T and B cells (Halim et al., 2012; Oboki et al., 2010) . Thus, it is thought that pathogen-or plant-derived proteases, which are distinct from pathogen-associated molecular patterns, can initiate antigen-non-specific allergic inflammation via activation of the innate immune system by causing release of alarmins such as IL-33 from damaged epithelial cells (Kiss et al., 2007) , which is later followed by establishment of antigen-specific allergic re- sponses via activation of the adaptive immunity (Sokol et al., 2008) . Like NH cells, mast cells (MCs) are considered to be major effector cells in certain allergic disorders and can secrete a variety of inflammatory mediators in response to IL-33 even in the absence of immunoglobulin E (IgE) (Ho et al., 2007; Iikura et al., 2007) . Therefore, we hypothesized that MCs can cooperate with NH cells in enhancing protease and IL-33-induced innatetype airway inflammation. However, in the present study, we found that IL-33-stimulated MCs can play a suppressive role in this setting by promoting an expansion of regulatory T (Treg) cell numbers that is dependent on MC-derived IL-2. Thus, MCs can negatively regulate the initiation phase of papain and IL-33-induced innate-type airway inflammation.
RESULTS

NH Cells Contribute to Protease-Mediated Eosinophilia
Inhalation of papain by mice resulted in the dose-dependent development of airway inflammation accompanied by accumulation of macrophages, eosinophils, neutrophils, lymphocytes, and natural helper (NH) cells in the bronchoalveolar lavage fluid (BALF), increased numbers of NH cells and MCs in the lungs, and increased concentration of IL-5 and IL-13, but not IL-4, in the BALF ( Figure 1A ). Inhalation of a high dose of papain (100 mg), but not of a lower dose of papain (25 mg), resulted in hemorrhage associated with destruction of blood vessel walls, as well as lung epithelial cells, presumably reflecting the strong proteinase activities of papain (Kamijo et al., 2013) . Indeed, high-dose papainmediated airway inflammation is considered to be a model for COPD (Chapman, 2008) . The histology of lungs from mice treated with 25 mg papain resembled that seen in asthma (in that eosinophils are prominent), whereas the lung pathology in mice treated with 100 mg papain had features of COPD, including enlarged airspaces ( Figure S1A ). The pathology induced by 50 mg papain showed an intermediate phenotype ( Figure S1A ). In association with increases in the numbers of eosinophils in BALFs (Figure S1C ), the expression of IL-33 mRNA in the lungs (Figure S1B ), the numbers of MCs in the lungs ( Figure S1C ), and numbers of NH cells in the BALFs and the lungs ( Figure S1D ) were significantly increased 24 hr after the 1 st or 2 nd papain inhalation. Consistent with previous studies (Halim et al., 2012; Oboki et al., 2010) , airway eosinophilia, but not neutrophilia, was significantly attenuated 24 hr after the 3 rd papain inhalation in Il33 À/À mice, in Rag2
mice, which had been depleted of NH cells by injection of anti-CD25 mAb, and in Rag2 À/À Il2rg À/À mice, which lack NH cells as well as T, B, NKT, and NK cells (Moro et al., 2010) (Figures 1B-1D ). As reported previously (Halim et al., 2012) , the impaired airway eosinophilia 24 hr after the 3 rd papain inhalation that was seen in Rag2
Il2rg
À/À mice was partially restored to that seen in wild-type mice by injection of NH cells into Rag2 Figure 1D ). In addition, papain-IL-33-NH-cell-mediated airway eosinophilia and lung expression of IL-33 mRNA 24 hr after the 3 rd papain inhalation were also significantly, albeit partially, suppressed in mice deficient in protease-activated receptor 2 (Par2) ( Figure 1E ). Immunoreactive IL-33 protein was detected in the nuclei of alveolar epithelial cells from wild-type mice, but not Il33 À/À mice, 24 hr after the 3 rd inhalation of papain, but not after inhalation of heat-inactivated papain ( Figure 1F ). This suggests that IL-33 released from alveolar epithelial cells by papain, at least in part through Par2, activates lung NH cells, followed by induction of airway eosinophilia (hereinafter called papain-IL-33-NH-cellmediated airway eosinophilia).
MCs Suppress NH Cell-Mediated Eosinophilia
Because IL-33 induces mast cells (MCs) to secrete Th2 type-cytokines (Ho et al., 2007; Iikura et al., 2007) Figure 2A ). In contrast, the responses in the two groups were not significantly different when the mice were treated with high-dose papain, which induced strong responses in all groups ( Figure S2A ). Likewise, papain-IL-33-NH-cell-mediated airway eosinophilia was exacerbated in Rag2 À/À mice compared with wild-type mice after inhalation of low-dose papain ( Figure 2B ), but not in the strong reactions that occurred after inhalation of high-dose papain ( Figure S2A ). In accord with these findings, the amounts of IL-5 and IL- Figure 2D ; Figures S2F and S2G ), but such differences were not observed in the strong responses that occurred after inhalation of high-dose IL-33 ( Figure S2H mice which lack abnormalities in c-Kit (Reber et al., 2012; Rodewald and Feyerabend, 2012) . In the present model system, we confirmed that the exacerbated airway eosinophilia induced by low-dose IL-33 was also observed in MC-depleted Mas-TRECK mice ( Figure S2I ). We also found that the amounts of IL-5 and IL-13 in the BALF from papain-treated mice were substantially lower than those from IL-33-treated mice (Figures 2A, 2B , and 2D), perhaps because these cytokines, which contain cysteine residues, can be directly degraded by papain ( Figure S2J ).
Taken together, these observations suggest that MCs and rag-dependent immune cells suppress airway eosinophilia induced by optimal doses of papain or IL-33.
Treg Cells Can Suppress NH Cell-Mediated Eosinophilia
The above observations suggest that MCs and Rag-dependent immune cells such as T, B, and/or NKT cells can play regulatory roles in airway eosinophilia induced by certain doses of papain and IL-33. Lymphocytes were very sparse in BALF from salinetreated wild-type mice, but significantly increased in number in BALF from papain-challenged wild-type mice ( Figure 1A ). After inhalation of papain or IL-33, the proportion and number of CD25 +
Foxp3
+ Treg cells in CD4 + T cells in BALF from wild-type mice increased ( Figure 3A ). In accord with this, the proportion and/or number of Treg cells was significantly increased in thoracic LNs, but not the spleen, from papain-or IL-33-treated wild-type mice compared with naive wild-type mice ( Figure 3A ). Like IL-5 and IL-13 ( Figure S2J ), IL-33 also can be degraded by papain (data not shown). Indeed, we could not detect IL-33 in the BALF of wild-type mice after papain inhalation (data not shown), despite the ability of papain to induce increased expression of IL-33 in the nuclei of airway epithelial cells ( Figure 1F ), perhaps because papain-induced IL-33 was degraded by papain. Therefore, the amounts of IL-33 in the BALF of papain-treated mice were substantially lower than those in the BALF of IL-33-treated mice, and this was associated with different numbers of Treg cells in papain-and IL-33-treated mice. In addition, when lymphocytes were cultured with papain, heat-inactivated papain, or IL-33, papain, but not heat-inactivated papain or IL-33, induced cell death (data not shown). Such effects of papain might account for why numbers of Treg cells in the BALF, but not in LNs, might be smaller in papain-treated mice than in IL33-treated mice. attenuating effect as noted above for Rag2 À/À mice ( Figure 3F ). Thus, MCs can influence expansion of numbers of Treg cells during papain-IL-33-NH-cellmediated airway eosinophilia.
Mast Cells Induce Treg Cell Number Expansion
We observed close associations between mast cells and Treg cells in the lungs of mice after papain inhalation ( Figure S4A ). Figure 4C ). These in vitro results are consistent with the conclusion that IL-33-stimulated BMCMCs increase numbers of Treg cells primarily via expansion of numbers of committed Tregs, but might also induce some de novo Treg cell differentiation.
BMCMCs derived from mice deficient in IL-1RL1 (also called ST2) and MyD88, which are components of the IL-33 receptor and IL-33 signaling, respectively, failed to enhance Treg cell expansion upon stimulation with IL-33 ( Figure 4D ). IL-33 can stimulate MCs to secrete IL-6 ( Figure S4C ), which is a key cytokine for Th17-cell differentiation. In contrast, we detected no significant effect of MC-derived IL-6 on IL-33-mediated expansion of Treg cell number; nor did MCs expand Th17 or Th2 cell numbers ( Figure 4D ; Figure S4D ), probably because we did not use any TCR-mediated stimuli such as anti-CD3 mAb in the MC-whole CD4 + T cell co-cultures. conclusion, MHC class II (H2-Ab1)-deficient BMCMCs efficiently induced IL-33-mediated Treg cell expansion in MCwhole CD4 + T cell co-cultures ( Figure 4E ). In addition, Treg cell expansion in number in those co-cultures was not induced by LPS or IL-1b ( Figure S4E ), or by IgE ( Figures  S4E and S4G) , IL-13, IL-25, or TSLP ( Figure S4F ), even though the signal transduction pathway involving LPS and IL-1b via TLR4 and IL-1R, respectively, is shared by IL-33 via IL-33R.
We also found that IL-33 enhanced CD4 + CD25 + Foxp3 + Treg cell number expansion from human peripheral blood-derived CD4 + T cells in the presence, but not absence, of peripheral blood stem-cell-derived cultured human MCs in vitro ( Figure 4F Figure 5A ). These results suggest that the ability to secrete IL-10 is essential for the immunoregulatory function of the CD4 + CD25 + Treg cells that expanded in response to IL-33-mediated MC activation in vitro.
Microarray analysis indicates that mouse NH cells express IL-10R1 mRNA (Moro et al., 2010) . NH cells in BALF from papain-or IL-33-treated wild-type mice expressed IL-10R1 ( Figure 5B ). Moreover, proliferation by NH cells in response to IL-33, but not to IL-2, IL-25, or IL-2 + IL-25, was significantly inhibited by the addition of 0.5-50 ng/ml IL-10 ( Figure 5C ) or 10 ng/ml IL-10 ( Figure 5D ). In association with the inhibition of NH cell proliferation by IL-10, the amounts of IL-5 and IL-13 in the culture supernatants were also reduced in this setting ( Figures 5C and 5D ). In addition, we found that IL-10R1 mRNA also was expressed in human ILC2 ( Figure 5E ). Proliferation and IL-13 production by human ILC2s in response to IL-33 plus IL-2 was significantly suppressed when human ILC2s were co-cultured with human Treg cells ( Figure 5F ). These observations suggest that Treg cell-derived IL-10 may regulate NH cell function directly.
MC-Derived IL-2 in Treg Cell
Number Expansion MC-derived soluble factors and co-stimulatory molecules each can be important for MC-dependent T cell activation (Kashiwakura et al., 2004; Nakae et al., 2005) . We found that IL-33-and BMCMC-mediated Treg cell number expansion was largely, but not completely, inhibited by using a transmembrane filter to separate whole CD4 + T cells and BMCMCs ( Figure 6A ), suggesting that both soluble molecules and cell-cell proximity (perhaps because this allows engagement of membrane-associated molecules) are required for full induction of Treg cells. In addition to IL-6, IL-13, and TNF ( Figure S4C ), we found that IL-33 stimulation induced BMCMCs to produce TGF-b1 and IL-2 ( Figure S5A ), which are critical for Treg cell development and expansion in number, respectively (Josefowicz et al., 2012) , but not IL-10 ( Figure S5A ). Similarly, MCs purified from lungs produced IL-2 in response to 10 ng/ml IL-33 in vitro (20 ng/ml versus 273 ng/ml after medium versus IL-33 stimulation).
Notably, Il2
À/À BMCMCs, in contrast to Tgfb1 À/À or Il10
BMCMCs, failed to expand Treg cells in MC-whole CD4 + T cell co-cultures in the presence of IL-33 ( Figures 6B-6D ). Indeed, IL-2 production was also detected by immunohistochemistry in lung mast cells from papain-or IL-33-treated wild-type, but not Il2 À/À or Il1rl1 À/À , mice ( Figures S5B-S5E) .
Moreover, addition of neutralizing mAbs for IL-2, ICAM-1, CD86, or 4-1BBL, but not PD-L1, ICOSL, OX40L, CD80, or FasL, significantly decreased Treg cell expansion ( Figure 6E) . Thus, the co-stimulatory and adhesion molecules ICAM-1, CD86, and 4-1BBL and especially MC-derived IL-2 contribute to the Treg cell expansion in numbers observed in this system. Next, to investigate the role of IL-2 produced by MCs in vivo, we administered IL-33 intranasally to Kit W-sh/W-sh mice engrafted with wild-type or Il2 À/À BMCMCs. In wild-type BMCMC-engrafted mice, the numbers of eosinophils were reduced to the levels observed in wild-type mice after IL-33 inhalation (Figure 7A) . Figures 7B and 7C) . Similar results were observed in these mice after papain inhalation (Figure 7D) . When wild-type BMCMCs were co-cultured with lung epithelial cells (ECs) from wild-type or Il33 À/À mice in the presence of papain or heat-inactivated papain, wild-type BMCMCs co-cultured with wild-type ECs, but not with Il33 À/À ECs, produced IL-2 after papain stimulation ( Figure 7E ). These observations suggest that IL-33, induced by papain, stimulates MCs via IL-1RL1 to produce IL-2, which can in turn suppress papain/IL-33/NH-cell-mediated airway eosinophilia by promoting Treg-cell expansion in numbers. 
DISCUSSION
It is now well established that IL-33 can induce Th2 cell-type inflammation accompanied by eosinophils, i.e., IL-33 can have pro-inflammatory effects (Chackerian et al., 2007; Kondo et al., 2008; Kurowska-Stolarska et al., 2008; Schmitz et al., 2005; Xu et al., 2008) . Although IL-33 also can attenuate cardiomyocyte hypertrophy and cardiac fibrosis after pressure overload (Sanada et al., 2007) , the molecular mechanisms accounting for these effects of IL-33 are not fully understood. In the present study, we provide additional evidence that the plant-derived protease papain, which activates innate immune responses in a manner distinct from that of pathogen-associated molecular patterns such as LPS, can induce secretion of an alarmin, IL- 33, by lung epithelial cells to induce NHcell-mediated acute allergic inflammation in the lungs of naive mice, and showed that this effect of papain on lung epithelial cells is in part dependent on Par2. We found that IL-33 protein was barely detectable in lung epithelial cells from heat-inactivated papain-treated wild-type mice. By contrast, high amounts of IL-33 protein expression were observed in lung epithelial cells of naive and PBS-treated IL-33-reporter mice (Pichery et al., 2012) . In contrast, constitutive IL-33 protein expression was detected in airway epithelial cells from PBS-treated IL-33-reporter mice, although the levels of IL-33 protein expression were lower in these cells and the frequency of IL-33-positive cells was much lower in lungs from PBS-treated IL-33-reporter mice than antigen-challenged IL-33-reporter mice (Hardman et al., 2013) . We do not know the reason for the differences among our results and those of Pichery et al. and Hardman et al. and can only speculate that they might reflect differences in the animals' housing conditions (i.e., under SPF conditions or conventional conditions) and/or other factors that remain to be defined.
Although IgE-stimulated mast cells are well known to have potent effector cell functions in the pathology of allergic disorders, we have provided multiple lines of evidence that IL-33-stimulated mast cells can play a regulatory role in the development of NH-cell-mediated non-antigen-specific protease-induced acute inflammation. Our evidence indicates that MCs can do this by producing IL-2 that in turn enhances Treg cell expansion in naive mice that lack antigen-specific IgE. IgE and specific Ag, but not IL-33, can induce degranulation of MCs (Ho et al., 2007; Iikura et al., 2007) . By contrast, we found that IL-33-stimulated MCs, but not IgE and Ag-stimulated MCs, can induce Treg cell expansion. Moreover, IgE and Ag-stimulated mast cells and Treg cells can suppress each other's function in the setting of anaphylaxis (Gri et al., 2008; Piconese et al., 2009) . Thus, MCs appear to play distinctly different, indeed opposite, roles in the induction of the acute phase of papaininduced innate allergic inflammation in naive mice (in which MCs downregulate the response) and in antigen-sensitized mice bearing antigen-specific-IgE (in which MCs have a major role in initiating and amplifying the response).
MCs can negatively regulate innate or adaptive immune responses in mice. For example, MCs have been reported to pro- mote peripheral tolerance to skin allografts (Lu et al., 2006) . In contrast to wild-type mice, MC-deficient Kit W-sh/W-sh mice that received donor-specific transfusion and anti-CD154 Ab treatment to induce tolerance exhibited significantly impaired survival of allogenic skin grafts (Lu et al., 2006) . It was proposed that Treg-cellderived IL-9 induced MC activation in the allografts, and that MC activation, and perhaps IL-10, contributed to the effectiveness of Treg-cell-mediated allograft tolerance (Lu et al., 2006) . These findings are consistent with the interpretation that MCs function downstream of Treg cells in enhancing tolerance to skin allografts, but the exact relationship between mast cells and Treg cells in this model remains to be determined. In other settings, MCs have been reported to exert anti-inflammatory or immunosuppressive effects via the production of histamine (Hart et al., 1998) or by unknown mechanisms (Depinay et al., 2006) . It has also been reported that IgG-stimulated MC-derived IL-10 or IgE-stimulated MC-derived IL-2 can have effects that suppress the chronic phase of local inflammation in certain models of contact hypersensitivity (Grimbaldeston et al., 2007; Hershko et al., 2011 Taken together, our findings suggest that IL-33 and MCs can play an anti-inflammatory or immunosuppressive negative-feedback role based on a pathway comprising IL-33-stimulated induction of MC-derived IL-2 leading to expansion of IL-10-producing CD4 + CD25 + Foxp3 + regulatory T cells (by a mechanism that is enhanced by mast cell-T cell proximity). The Treg cells can then downregulate tissue inflammation.
EXPERIMENTAL PROCEDURES
Mice C57BL/6J and C57BL/6N wild-type (Japan SLC), C57BL/6N-Il33 À/À (Oboki et al., 2010) , C57BL/6J-Mas-TRECK (Otsuka et al., 2011) , C57BL/6-Rag2
À/À and 129 3 B6-Tgfb1
, C57BL/6-Foxp3-GFP, and C57BL/6-Il1rl1 À/À mice were used. All experiments were conducted in accordance with the institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation.
Papain-and IL-33-Mediated Airway Inflammation
Mice were treated with papain (Calbiochem; 25 mg as a low-dose protocol and 50-100 mg as a high-dose protocol) or recombinant human IL-33 (rhIL-33: PeproTech; 0.1 mg as a low-dose protocol and 5 mg as a high-dose protocol) in 20 ml of sterile, pyrogen-free 0.9% NaCl (''saline'') i.n. for 3 days (one inhalation per day) unless otherwise specified. As controls, mice were treated with an equal volume of heat-inactivated papain or saline alone.
Bronchoalveolar Lavage Fluid
Bronchoalveolar lavage fluid (BALF) was collected from naive mice or mice 24 hr after the last challenge with papain or IL-33, as described elsewhere (Oboki et al., 2010 NH cells were isolated as described previously (Moro et al., 2010) with minor modifications. For transfer of NH cells into Rag2 À/À Il2rg À/À mice, freshly isolated NH cells were cultured in the presence of 10 ng/ml rmIL-2 at 37 C for 1-2 months (Furusawa et al., 2013) . The expanded NH cells (4 3 10 6 cells/mouse) were then intravenously injected into Rag2 À/À Il2rg À/À mice.
One day after injection, the mice were intranasally treated with papain as described above. NH cells (5,000 cells/well in a 96-well round-bottom plate) were cultured in the presence and absence of 10 ng/ml rmIL-33, rmIL-25, and rmIL-2, with and without 10 ng/ml IL-10, at 37 C for 5 days. The concentrations of IL-5
and IL-13 in the culture supernatants were measured by ELISA. Human ILC2-Treg Cell Co-culture Human ILC2 were prepared as described previously (Mjö sberg et al., 2012) , with minor modifications. CD4 + CD25 high CD127 dim/À Treg cells were enriched from PBMCs of healthy donors using a human CD4 + CD25 + CD127 dim/À regulatory T cell Isolation Kit II (Miltenyi Biotec) according to the manufacturer's instructions and then sorted on a FACS Aria. ILC2 (1 3 10 4 cells/well) in 96-well round-bottom plates were co-cultured with different numbers of autologous Treg cells in the presence of 10 U/ml rhIL-2 and 50 ng/ml rhIL-33 at 37 C for 3 days. After 3 days, the cells were harvested and sorted again with a FACS Aria. The expression levels of IL-5 and IL-13 were determined by quantitative PCR.
Statistical Analyses
Unless otherwise specified, data show the mean ± /+ SEM and were evaluated for statistical significance using the two-tailed Student's t test.
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